Review of the clinicopathologic features of fibrolamellar carcinoma.
about
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.Unique genomic profile of fibrolamellar hepatocellular carcinoma.DNAJB1-PRKACA is specific for fibrolamellar carcinoma.Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomasFrequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver.Fibrolamellar carcinomas are positive for CD68Fibrolamellar hepatocellular carcinoma: a case report with distinct radiological features.Cell cycle biology of fibrolamellar hepatocellular carcinomaChromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.Cold agglutinin disease in fibrolamellar hepatocellular carcinoma: a rare association with a rare cancer variant.Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients.Prognostic factors in fibrolamellar hepatocellular carcinoma in young peopleA genomic case study of mixed fibrolamellar hepatocellular carcinomaFibrolamellar carcinoma: 2012 updateAnterior gradient-2 is overexpressed by fibrolamellar carcinomas.Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.Fibrolamellar hepatocellular carcinoma.Oncocytic mania: a review of oncocytic lesions throughout the body.Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection.Liver transplantation for fibrolamellar hepatocellular carcinoma: A national perspective.Molecular characteristics of fibrolamellar hepatocellular carcinoma.Hepatocellular carcinoma: a clinicopathological study of 64 casesMolecular testing for the clinical diagnosis of fibrolamellar carcinoma.Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.Fibrolamellar hepatocellular carcinoma with cardiac spread causing severe inferior vena cava obstruction in a 9-year-old child.Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma.Environmental exposures as a risk factor for fibrolamellar carcinoma.[Tumor grading of the hepatobiliary system].Fibrolamellar hepatocellular carcinoma in ascitic fluid: A case report with cytohistological correlation.
P2860
Q26998606-6AE3080A-9898-4BE6-9400-8AEED70C8044Q27852915-23B64360-F470-452F-B43A-1640C2BBC77AQ27853116-8D8FB814-93DF-4180-A95A-13CF860B20D5Q27853135-00AAA712-351B-4522-9D00-2A43DF52A2ADQ33540676-82B40352-7DD5-401B-BA9D-55CB696ACE18Q33742006-079B547B-03B4-4CBB-858D-5D257AEF2B8BQ33757399-C86F338E-13F2-42B9-B34F-ECE621AAAE51Q33824403-06D2400D-B837-42B9-8176-9FDCEEF81568Q34357930-3B72F841-4B4C-4650-AC42-F6CF4B1B5AB4Q34703712-7FD7C903-CDDC-4A80-801C-4EE8EB4D50E4Q35008668-F7A9A7AF-FBC3-4243-8A27-F5DE78C6225BQ35666625-2EDE27BE-3D08-4606-9187-86E740A007E4Q35995839-121EC18A-979B-4298-B8F1-5EDB88D13989Q36023427-1E5D73F0-DCA5-4994-A5E5-55CED6C96EEEQ36935210-A831F864-3466-4DEB-86DE-7A82228624FAQ37288706-521D5086-FE21-4CA4-B782-8A029BDB3A13Q37352343-0F810E25-24E3-499A-81C0-3D19BCBDC31FQ37553809-89E5E936-F6CD-408A-B424-59DCEC1390F2Q37565016-E1951111-87F5-42A1-9DBC-687BE08DCE54Q37837353-19651F73-17CC-4379-9446-F01C51CD1ADDQ37993500-ABD38838-B62D-487D-A794-7A5E5D38500EQ39160124-76A47125-2389-4809-B0B2-7804E8F8B2D1Q40055042-6E59A6C3-3419-4CFC-8C9F-6CA611398972Q41056079-9A0DFD2A-6056-478F-B75E-7E66760D2BABQ46447893-8CB8DE0F-8009-4B2F-9C51-6ECDC45079AAQ46545465-C1CF5CE2-CE8F-46FE-AFA4-828E393F79DDQ46688979-8750EC85-4025-43BB-B788-33956C914E02Q47635386-61237B9D-3DEF-4C61-BFC9-4BC1756BBA22Q50152242-B5CD154B-B49B-43E3-AD94-077076B89786Q51139296-0A05B626-66ED-4F87-B424-4D2D9503BF20Q52897650-28702239-A071-4701-BCD5-A68F651FEA99Q53079235-ADEF912F-ED27-4E28-BE99-9B381365A6FAQ53095616-C6206416-D7FD-4BF0-BC24-A304F69EE8FC
P2860
Review of the clinicopathologic features of fibrolamellar carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Review of the clinicopathologic features of fibrolamellar carcinoma.
@en
type
label
Review of the clinicopathologic features of fibrolamellar carcinoma.
@en
prefLabel
Review of the clinicopathologic features of fibrolamellar carcinoma.
@en
P1476
Review of the clinicopathologic features of fibrolamellar carcinoma.
@en
P2093
Michael Torbenson
P304
P356
10.1097/PAP.0B013E3180504913
P577
2007-05-01T00:00:00Z